Aperam Shares Drop 7.2% in a Week Following JP Morgan Downgrade
Aperam's stock experienced a sharp decline this Wednesday, March 11, dropping 2.4% to 35.86 euros during the session, in a European market that was also trending downward. The stock has now accumulated a 7.2% loss over seven days, erasing some of the gains made in the last three months. This downturn follows a significant revision of JP Morgan's recommendation.
Change in JP Morgan's Stance
The American bank JP Morgan has altered its stance on Aperam's stock, shifting from an 'overweight' recommendation to 'neutral'. Concurrently, the price target was reduced from 45.10 euros to 40.70 euros, which still represents a potential upside of about 13.5% from the current price of 35.86 euros. This change in tone from one of the major international brokers directly impacts the stock in this Wednesday's session.
The market context does not help Aperam to withstand pressure. The CAC 40 is down by 0.58% during the session, while the DAX has lost 1.58%. The VIX, a volatility indicator, was at 29.49 points in its last reading on March 6, a level indicating high tension in the markets. This general nervousness increases the selling pressure on cyclical stocks such as the stainless steel producer.
Technical Deterioration
Technically, Aperam's trajectory has significantly worsened in recent sessions. The price of 35.86 euros is now well below its 50-day moving average at 38.35 euros, and also under its 20-day moving average (41.41 euros). This configuration reflects a short-term bearish dynamic, confirmed by an RSI at 34, which signals a potential oversold zone. This level indicates strong selling pressure, without necessarily guaranteeing an imminent rebound.
The nearest support threshold is at 34.74 euros, just barely 3% below the current price. The lower Bollinger band, at 35.97 euros, has already been approached during the session, illustrating the magnitude of the bearish movement. Despite this marked weekly decline, the stock still shows an increase of 8.47% over three months and 13.41% over a year, supported by a 200-day moving average that remains well below the current price, at 31.38 euros.
